Apexigen, Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was USD 32.07 million compared to USD 28.92 million a year ago. Basic loss per share from continuing operations was USD 1.62 compared to USD 1.6 a year ago.
1st Jan change | Capi. | |
---|---|---|
+20.63% | 126B | |
+24.16% | 27.95B | |
-20.17% | 20.5B | |
-16.06% | 17.12B | |
-18.07% | 16.1B | |
-47.70% | 14.97B | |
+11.92% | 14.84B | |
+58.32% | 14.38B | |
+149.98% | 12.37B |